USCA Xtrackers MSCI USA Climate Action Equity ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| NVDA | 5.60% |
| AVGO | 4.73% |
| MSFT | 4.46% |
| AMZN | 4.36% |
| META | 3.45% |
| TSLA | 2.95% |
| GOOGL | 2.84% |
| GOOG | 2.35% |
| JPM | 2.20% |
| LLY | 2.10% |
ETF Analysis
Fund Overview
Xtrackers MSCI USA Climate Action Equity ETF (USCA) currently reports 271 stock positions (subject to change), placing it in the highly diversified range by holdings breadth. The top line-up is NVDA (5.60%), AVGO (4.73%), MSFT (4.46%), with NVDA as the largest single weight at 5.60%. Together, the top three holdings account for 14.79%, which implies a more democratized weight structure where the broader holding set matters as much as the leadership group. This structure gives the portfolio a dual character: meaningful exposure to its highest-conviction names, alongside enough breadth to dampen idiosyncratic noise.
Profitability & Capital Efficiency
Examining the portfolio through a capital allocation lens, ROIC is 27.37%, WACC is 9.32%, and the economic spread is 18.05%. On balance, the spread between ROIC and WACC is solidly positive — reinvestment is adding value rather than diluting it. Supporting metrics show ROE at 35.56% and ROA at 11.30%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
Valuation currently screens at trailing P/E of 26.18, forward P/E of 20.44, PEG of 1.99. Trailing and forward multiples are somewhat apart, indicating the market is pricing measured earnings growth without aggressive expansion assumptions. Growth-adjusted valuation is in a reasonable range, with the multiple broadly in line with expected earnings expansion. The aggregate current ratio of 1.65 reflects a holding set with workable near-term liquidity positions. The valuation profile here is neither obviously cheap nor dramatically expensive — a setup where the return case is built more on earnings delivery than on re-rating potential.
Margins & Cash Generation
From gross to free cash flow, gross margin sits at 58.90%, operating margin at 27.28%, and free cash flow margin at 21.94%. At this gross margin level, the holdings demonstrate adequate production efficiency without commanding premium pricing. The operating margin reading is healthy — adequate to support reinvestment without sacrificing profitability. The portfolio's FCF margin is above average, pointing to holdings with efficient capital deployment and durable cash generation. Taken together, the margin profile reflects a collection of businesses with genuine competitive advantages — capable of sustaining profitability and generating cash across a range of economic conditions.
Growth & Forward Outlook
Revenue momentum and analyst targets together paint a picture where the estimated 12-month price change of 24.52%, where consensus expectations favor gradual appreciation over the next year, while TTM revenue growth of 17.06% reflecting moderate but reliable revenue progress across the basket. Reported revenue growth is the operational foundation; the analyst target spread shows what the market is willing to pay above it — and that premium can evaporate quickly if delivery slips. For investors, the central question is whether the operating momentum visible in revenues is durable enough to support the price appreciation implied by consensus targets. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyWhen all the evidence is placed side by side, this profile stands out as one with genuine compounding characteristics and limited structural headwinds.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.